These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26061565)

  • 1. FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.
    Liu Z; Ren YA; Pangas SA; Adams J; Zhou W; Castrillon DH; Wilhelm D; Richards JS
    Mol Endocrinol; 2015 Jul; 29(7):1006-24. PubMed ID: 26061565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
    Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
    Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
    Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
    PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
    Richards JS; Fan HY; Liu Z; Tsoi M; Laguë MN; Boyer A; Boerboom D
    Oncogene; 2012 Mar; 31(12):1504-20. PubMed ID: 21860425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH.
    Liu Z; Castrillon DH; Zhou W; Richards JS
    Mol Endocrinol; 2013 Feb; 27(2):238-52. PubMed ID: 23322722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression.
    Laguë MN; Paquet M; Fan HY; Kaartinen MJ; Chu S; Jamin SP; Behringer RR; Fuller PJ; Mitchell A; Doré M; Huneault LM; Richards JS; Boerboom D
    Carcinogenesis; 2008 Nov; 29(11):2062-72. PubMed ID: 18687666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.
    Kyrönlahti A; Rämö M; Tamminen M; Unkila-Kallio L; Butzow R; Leminen A; Nemer M; Rahman N; Huhtaniemi I; Heikinheimo M; Anttonen M
    Endocrinology; 2008 Nov; 149(11):5635-42. PubMed ID: 18653721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
    Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mouse model of testicular granulosa cell tumors.
    Fang X; Ni N; Gao Y; Vincent DF; Bartholin L; Li Q
    Mol Hum Reprod; 2018 Jul; 24(7):343-356. PubMed ID: 29788434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXL2-induced follistatin attenuates activin A-stimulated cell proliferation in human granulosa cell tumors.
    Cheng JC; Chang HM; Qiu X; Fang L; Leung PC
    Biochem Biophys Res Commun; 2014 Jan; 443(2):537-42. PubMed ID: 24332943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of Differential Phosphorylation Sites of the Nuclear FOXL2 Protein as Potential Novel Biomarkers for Adult-Type Granulosa Cell Tumors.
    Suh DS; Oh HK; Kim JH; Park S; Shin E; Lee K; Kim YH; Bae J
    J Proteome Res; 2015 Jun; 14(6):2446-56. PubMed ID: 25871347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
    Rosario R; Araki H; Print CG; Shelling AN
    PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
    Gao Y; Fang X; Vincent DF; Threadgill DW; Bartholin L; Li Q
    Reprod Biol Endocrinol; 2017 Dec; 15(1):94. PubMed ID: 29221447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children.
    Kalfa N; Fellous M; Boizet-Bonhoure B; Patte C; Duvillard P; Pienkowski C; Jaubert F; Ecochard A; Sultan C
    J Urol; 2008 Oct; 180(4 Suppl):1810-3. PubMed ID: 18721930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
    Bittinger S; Alexiadis M; Fuller PJ
    Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
    Leung DTH; Fuller PJ; Chu S
    Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO1 mitigates the SMAD3/FOXL2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.